Eli Lilly & Co./Faktor/Short [15]/BNP
- BID
0.69
- ASK
0.79
- 45,000 Units45,000 Units
- 07/23, 13:35:27 PM
Product class
Factor - Factor Warrant - with Leverage
First exchange day
01/06/2026
Last exchange day
Open End
Performance (1M)
87.11%
Factor type
short
Factor
15.00
Trade further factor warrants for Eli Lilly and Company without exchange fees.
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.68 G | 0 Units |
| PRICE DETERMINATION TIME | 07/23/2026 / 01:12:26 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.68 | 0.66 |
| PREV. DAY'S PRICE | 0.66 | (07/22) |
| CHANGE DAY BEFORE | +0.02 | 3.03 % |
| 52 WEEK HIGH / LOW | (-) | (-) |
Master Data
| WKN | PM3N57 |
| ISIN | DE000PM3N575 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Leverage Product |
| PRODUCT CLASS | Factor - Factor Warrant - with Leverage |
| PRODUCT NAME | ELI LILLY & CO. Faktor 15 Short |
| ISSUER | BNP Paribas Emissions- und Handelsgesellschaft mbH |
| TRADING SEGMENT | - |
| FACTOR TYPE | short |
| UNDERLYING | ELI LILLY AND COMPANY COM NPV |
| UNDERLYING INSTRUMENT | ELI LILLY AND COMPANY COM NPV |
| FACTOR | 15.00 |
| MULTIPLIER | 1.00 |
| EXERCISE TYPE | American |
| TRADING CURRENCY NOTE | Euro / Units |
| NOMINAL CURRENCY | EUR |
| SETTLEMENT CURRENCY | Euro |
| SMALLEST TRADABLE UNIT | 1.00 |
| MINIMUM QUOTATION EUR | 0.00 |
| MINIMUM QUOTATION UNITS | 0.00 |
| LAST VALUATION DAY | Open End |
| PAYMENT DATE | - |
| FIRST EXCHANGE DAY | 01/06/2026 |
| LAST EXCHANGE DAY | Open End |
| TRADING HOURS | - |
| QUOTATION | - |
| ISSUE VOLUME | 2,500,000 |
| QUANTO | No |
Issuer
| NAME | BNP Paribas Emissions- und Handelsgesellschaft mbH |
| ADDRESS | BNP Paribas
Zertifikate und Hebelprodukte
Senckenberganlage 19
60325 Frankfurt am Main
Deutschland |
| EMAIL ADDRESS | derivate@bnpparibas.com |
| SERVICE PHONE NUMBER | +49 (0) 69 7193 - 3111 |
| URL | https://derivate.bnpparibas.com |
Product Description
This factor warrant provides the investor with a constant leverage of 15.00 to participate in the positive and negative performance of the Eli Lilly & Co., which is the underlying instrument. This product has an unlimited term. The issuer has the right to terminate the warrant, subject to a specific notice period.